Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections

Lupus

Volumn 23, Issue 14, 2014, Pages 1512-1516

  Luijten, R K M A C ^a   Cuppen, B V J ^a   Bijlsma, J W J ^a   Derksen, R H W M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

infections; Systemic lupus erythematosus; vaccination

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BLADDER CATHETERIZATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PARAPLEGIA; PARKINSON DISEASE; PATHOGENESIS; PNEUMOCOCCAL INFECTION; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; URINARY TRACT INFECTION; ADOLESCENT; COMPLICATION; ESCHERICHIA COLI INFECTIONS; HOSPITALIZATION; INCIDENCE; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; NETHERLANDS; PNEUMONIA, PNEUMOCOCCAL; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; ESCHERICHIA COLI INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NETHERLANDS; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84911062706     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314543918     Document Type: Article

References (15)

1. Goldblatt F, Chambers S, Rahman A, Isenberg DA. Serious infections in British patients with systemic lupus erythematosus: Hospitalisations and mortality. Lupus. 2009 ; 18: 682-689
2. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003 ; 82: 299-308
3. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am. 1998 ; 24: 423-456
4. Millet A, Decaux O, Perlat A, Grosbois B, Jego P. Systemic lupus erythematosus and vaccination. Eur J Intern Med. 2009 ; 20: 236-241
5. Hill MD, Karsh J. Invasive soft tissue infections with Streptococcus pneumoniae in patients with systemic lupus erythematosus: Case report and review of the literature. Arthritis Rheum. 1997 ; 40: 1716-1719
6. Al-Rayes H, Al-Swailem R, Arfin M, Sobki S, Rizvi S, Tariq M. Systemic lupus erythematosus and infections: A retrospective study in Saudis. Lupus. 2007 ; 16: 755-763
7. Bosch X, Guilabert A, Pallares L, et al. Infections in systemic lupus erythematosus: A prospective and controlled study of 110 patients. Lupus. 2006 ; 15: 584-589
8. Noel V, Lortholary O, Casassus P, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis. 2001 ; 60: 1141-1144
9. Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C. Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther. 2009 ; 11: R109 - R109
10. Jansen AG, Rodenburg GD, de Greeff SC, et al. Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits. Vaccine. 2009 ; 27: 2394-2401
11. Kamen DL. How can we reduce the risk of serious infection for patients with systemic lupus erythematosus?. Arthritis Res Ther. 2009 ; 11: 129-129
12. Mosca M, Tani C, Aringer M, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010 ; 69: 1269-1274
13. Barber C, Gold WL, Fortin PR. Infections in the lupus patient: Perspectives on prevention. Curr Opin Rheumatol. 2011 ; 23: 358-365
14. Hakkaart-van Roijen L TSBC. Handleiding voor kostenonderzoek. Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. College voor Zorgverzekeringen. College voor Zorgverzekeringen, 2010.
15. Elkayam O, Paran D, Caspi D, et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis. 2002 ; 34: 147-153